Essential genetic mutations impair DNA damage repair and modulate tumor immune microenvironment in ccRCC

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• Targeting DNA damage repair (DDR) defects is a proven strategy in solid tumors with specific genetic mutations.
• Clear cell renal cell carcinoma (ccRCC) exhibits intermediate genomic instability but lacks common DDR gene mutations.
• Key genetic alterations in ccRCC include chromosome 3p loss, von Hippel-Lindau (VHL) gene inactivation, and mutations in PBRM1, SETD2, and BAP1.

Purpose of the Study:

• To summarize and discuss how specific genetic mutations in ccRCC impact DDR pathways.
• To explore the activation of cytosolic DNA sensing pathways due to these mutations.
• To analyze alterations in the tumor immune microenvironment and identify potential therapeutic targets in ccRCC.

Main Methods:

• Literature review and synthesis of existing research on ccRCC genetics and DDR.
• Analysis of the functional consequences of ccRCC-associated mutations on DNA repair mechanisms.
• Review of studies investigating the interplay between ccRCC genetic alterations, immune microenvironment, and therapeutic strategies.

Main Results:

• Specific mutations in ccRCC impair DNA damage repair (DDR) pathways.
• These genetic alterations lead to the activation of cytosolic DNA sensing pathways.
• The tumor immune microenvironment is significantly altered by these genetic changes, presenting therapeutic opportunities.

Conclusions:

• The unique genetic landscape of ccRCC, despite lacking canonical DDR mutations, offers distinct vulnerabilities.
• Understanding how ccRCC mutations affect DDR and immune signaling is crucial for developing targeted therapies.
• Exploring therapeutic strategies that leverage impaired DDR and altered immunity holds promise for ccRCC treatment.